EIGR 8.5 (+0%)
US28249U1051BiotechnologyBiotechnology

Eiger BioPharmaceuticals (EIGR) Financial Metrics

This table shows a selected set of financial data points of Eiger BioPharmaceuticals (EIGR). You can choose which elements to display by selecting the desired chart and column.

MarketCap

Total Revenue

Free CashFlow

Year EPS Dividend Yield PE Ratio MarketCap Return On Assets Total Revenue Free CashFlow EBITDA Net Income Cash
2022 -69.74 0 -0.02 1.64M -0.79 13.48M -83.35M -91.78M -96.78M 25.8M
2021 -29.98 0 -0.17 5.87M -0.25 12.14M -120.07M -29.5M -33.92M 22.22M
2020 -69.34 0 -0.18 11.53M -0.52 0 -63.44M -60.81M -65.05M 28.86M
2019 -3.08 0 -4.83 339.51M -0.68 0 -64.09M -66.36M -70.25M 39.37M
2018 -3.82 0 -2.66 139.3M -0.72 0 -42.81M -50.01M -52.39M 61.26M
2017 -4.86 0 -2.87 121.75M -0.82 0 -38.42M -40.88M -42.45M 32.04M
2016 -7.84 0 -1.49 69.98M -1 0 -38.03M -46.37M -47.09M 27.76M
2015 -27.93 0 -0.79 35.06M -0.72 0 -41.33M -41.61M -44.41M 32.78M
2014 -21.62 0 -13.55 458.78M -0.61 0 -30M -32.96M -33.85M 14.44M
2013 -16.97 0 0 0 -0.7 0 -16.28M -19.87M -20M 7.9M
2012 -27.51 0 0 0 -0.87 0 -14.69M -15.55M -15.72M 13.84M
2010 -12.23 0 0 0 0 0 -5.61M -5.79M -6.99M 0

Obligatory risk notice

We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.